quinapril has been researched along with Diabetic Glomerulosclerosis in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (7.14) | 18.2507 |
| 2000's | 11 (78.57) | 29.6817 |
| 2010's | 2 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fang, L; Kökény, G; Mózes, MM; Révész, C; Rosivall, L; Szénási, G; Vörös, P | 1 |
| Aktas, C; Cevat, A; Dogutan, H; Kanter, M; Mehmet, K; Omer, Y; Saniye, S; Sedat, U; Sen, S; Ustundag, S; Yalcin, O | 1 |
| Allen, TJ; Cooper, ME; de Gasparo, M; Feng, B; Jandeleit-Dahm, KA; Li, J; Schumacher, C; Thomas, MC; Watson, AM | 1 |
| Bicket, DP | 1 |
| Blanco, S; Casas, I; López, D; Penin, R; Romero, R | 1 |
| Fujita, T; Goto, A; Onozato, ML; Tojo, A | 1 |
| Blanco, S; Bonet, J; Casas, I; López, D; Romero, R | 1 |
| Blanco, S; Egido, J; Gómez-Guerrero, C; López, D; Romero, R; Vaquero, M | 1 |
| Chua, CL; Goh, SK; Heng, BL; Koh, AF; Lim, SC; Subramaniam, T; Sum, CF | 1 |
| Chen, H; Clyne, S; Han, E; Harris, R; Lehrich, R; Lewis, J; Middleton, J; Rodby, R; Schulman, G; Shyr, Y; Sika, M; Sinsakul, M | 1 |
| Barthelmebs, M; Grima, M; Imbs, JL; Jund, A; Petitjean, P; Stephan, D; Vloemans, M | 1 |
| Artero, M; Bardelli, M; Bortoletto, M; Candido, R; Carraro, M; Carretta, R; Cattin, MR; Fabris, B; Faccini, L; Fior, F; Fiorotto, A; Millevoi, C; Zennaro, C | 1 |
| Fujita, T; Goto, A; Onozato, ML; Tojo, A; Wilcox, CS | 1 |
1 review(s) available for quinapril and Diabetic Glomerulosclerosis
| Article | Year |
|---|---|
Using ACE inhibitors appropriately.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzazepines; Captopril; Cardiovascular Diseases; Clinical Trials as Topic; Contraindications; Diabetic Nephropathies; Drug Costs; Enalapril; Fosinopril; Heart Failure; Humans; Hypertension; Indoles; Isoquinolines; Lisinopril; Meta-Analysis as Topic; Myocardial Infarction; Perindopril; Quinapril; Ramipril; Renin-Angiotensin System; Risk; Tetrahydroisoquinolines; United States | 2002 |
2 trial(s) available for quinapril and Diabetic Glomerulosclerosis
| Article | Year |
|---|---|
Angiotensin receptor antagonist vs. angiotensin-converting enzyme inhibitor in Asian subjects with type 2 diabetes and albuminuria - a randomized crossover study.
Topics: Adult; Albuminuria; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Asian People; Cross-Over Studies; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Humans; Losartan; Male; Middle Aged; Quinapril; Singapore; Tetrahydroisoquinolines | 2007 |
A randomized trial of a 6-week course of celecoxib on proteinuria in diabetic kidney disease.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Celecoxib; Creatinine; Cross-Over Studies; Cyclooxygenase Inhibitors; Diabetic Nephropathies; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Humans; Middle Aged; Models, Statistical; Pilot Projects; Proteinuria; Pyrazoles; Quinapril; Sulfonamides; Tetrahydroisoquinolines | 2007 |
11 other study(ies) available for quinapril and Diabetic Glomerulosclerosis
| Article | Year |
|---|---|
The Effect of Combined Treatment with the (Pro)Renin Receptor Blocker HRP and Quinapril in Type 1 Diabetic Rats.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Drug Interactions; Drug Therapy, Combination; Kidney; Male; MAP Kinase Signaling System; Quinapril; Rats; Rats, Sprague-Dawley; Renin; Tetrahydroisoquinolines | 2017 |
Effect of angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on streptozotocin-induced diabetic nephropathy.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Biphenyl Compounds; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Drug Therapy, Combination; Female; Immunohistochemistry; Irbesartan; Kidney; Kidney Function Tests; Quinapril; Rats; Rats, Sprague-Dawley; Tetrahydroisoquinolines; Tetrazoles; Transforming Growth Factor beta1 | 2008 |
The endothelin receptor antagonist avosentan ameliorates nephropathy and atherosclerosis in diabetic apolipoprotein E knockout mice.
Topics: Animals; Antihypertensive Agents; Apolipoproteins E; Atherosclerosis; Blood Pressure; Diabetic Angiopathies; Diabetic Nephropathies; Disease Models, Animal; Endothelin Receptor Antagonists; Hyperglycemia; Hyperlipidemias; Kidney; Kidney Function Tests; Mice; Mice, Knockout; Pyridines; Pyrimidines; Quinapril; Tetrahydroisoquinolines | 2010 |
Adolescent type 1 Diabetes Cardio-renal Intervention Trial (AdDIT).
Topics: Adolescent; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Area Under Curve; Atorvastatin; Biomarkers; Cardiomyopathies; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Double-Blind Method; Drug Therapy, Combination; Dyslipidemias; Female; Follow-Up Studies; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Multicenter Studies as Topic; Puberty; Pyrroles; Quinapril; Randomized Controlled Trials as Topic; Research Design; Risk; Tetrahydroisoquinolines | 2009 |
Effects of antihypertensive drugs in experimental type 2 diabetes-related nephropathy.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Calcium Channel Blockers; Desmin; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diltiazem; Disease Models, Animal; Drug Therapy, Combination; Linear Models; Male; Obesity; Podocytes; Proteinuria; Quinapril; Rats; Rats, Zucker; Tetrahydroisoquinolines | 2002 |
Effect of combination therapy with dipyridamole and quinapril in diabetic nephropathy.
Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Glucose; Blotting, Western; Creatinine; Cyclic GMP; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Dipyridamole; Drug Therapy, Combination; Female; Immunohistochemistry; Isoquinolines; Kidney; Lipid Peroxides; NADH, NADPH Oxidoreductases; NADPH Oxidases; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Phosphodiesterase Inhibitors; Phosphoproteins; Quinapril; Random Allocation; Rats; Rats, Sprague-Dawley; Tetrahydroisoquinolines | 2003 |
ACE inhibitors improve nephrin expression in Zucker rats with glomerulosclerosis.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Calcium Channel Blockers; Desmin; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diltiazem; DNA, Complementary; Immunoenzyme Techniques; Male; Membrane Proteins; Microfilament Proteins; Obesity; Proteins; Quinapril; Rats; Rats, Zucker; Reverse Transcriptase Polymerase Chain Reaction; RNA; Tetrahydroisoquinolines | 2005 |
Potential role of angiotensin-converting enzyme inhibitors and statins on early podocyte damage in a model of type 2 diabetes mellitus, obesity, and mild hypertension.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Atorvastatin; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Models, Animal; Glomerulosclerosis, Focal Segmental; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Immunoenzyme Techniques; Kidney; Kidney Glomerulus; Linear Models; Microscopy, Electron; Obesity; Pyrroles; Quinapril; Rats; Rats, Zucker; Staining and Labeling; Tetrahydroisoquinolines | 2005 |
Short-term effects of quinapril and nifedipine on early renal changes in streptozotocin-induced diabetes in rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Glucose; Body Weight; Carbon Dioxide; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Dose-Response Relationship, Drug; Eating; Isoquinolines; Kidney; Male; Nifedipine; Oxygen; Partial Pressure; Peptidyl-Dipeptidase A; Quinapril; Rats; Rats, Wistar; Renal Circulation; Tetrahydroisoquinolines | 1994 |
Modulation of incipient glomerular lesions in experimental diabetic nephropathy by hypotensive and subhypotensive dosages of an ACE inhibitor.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Glucose; Blood Pressure; Body Weight; Diabetic Nephropathies; Dose-Response Relationship, Drug; Isoquinolines; Kidney; Kidney Glomerulus; Male; Peptidyl-Dipeptidase A; Permeability; Quinapril; Rats; Rats, Wistar; Serum Albumin; Tetrahydroisoquinolines | 2001 |
Oxidative stress and nitric oxide synthase in rat diabetic nephropathy: effects of ACEI and ARB.
Topics: Albuminuria; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Diabetic Nephropathies; Female; Hydrogen Peroxide; Isoquinolines; Kidney; Lipid Peroxidation; NADPH Oxidases; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type III; Oxidative Stress; Phosphoproteins; Proteinuria; Quinapril; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Superoxides; Tetrahydroisoquinolines; Tetrazoles; Tyrosine | 2002 |